Pharmaceutical Technology
May 02, 2006
Packaging Forum
30
5
Bringing Exubera to market requires extensive collaboration by Pfizer, Nektar Therapeutics, West Pharmaceutical Services Tech Group, and Bespak.
May 02, 2006
Outsourcing
30
5
Buyers strategically target chemistry, manufacturing, and controls development services.
May 02, 2006
Viewpoint
30
5
China's State Food and Drug Administration prepares to strengthen the enforcement of good manufacturing practices.
May 02, 2006
Articles
30
5
With single-enantiomer separations dominating the blockbuster charts, simulated moving bed chromatography and other multicolumn continuous chromatographic processes offer a quick route to clinical trial materials, along with the resolution, economy, and scalability to support tons-per-year production.
May 02, 2006
Articles
30
5
Using Bezier curves, an experimental process controller has been developed for biosynthesis applications in which the inactivity of a pH-sensitive enzyme must be decreased. By taking into account various control scenarios of pH and growth rate, as well as the physical and chemical characteristics of the environment, a suitable human-machine interface can be developed.
May 02, 2006
This Time Around
30
5
At this year's BIO conference, US Health and Human Services Secretary Mike Leavitt predicted that over the coming decade, "Medicine will be transformed from an instinctive art of alleviating symptoms to a science of personalized healthcare." Is industry ready?
May 02, 2006
Articles
30
5
Indian suppliers of active pharmaceutical ingredients and dosage formulations expand in India, the United States, and Europe.
May 02, 2006
From The Editor
30
5
From the most frenetic conference season in recent memory, trying to distill perspective from mental snapshots of Interphex, Wisconsin, and BIO 2006.
May 02, 2006
In the Field
30
5
Gottlieb challenges industry. First GenerationNext Awards. Implementing PAT. Optimizing site risk. RFID in the supply chain. Biodegradable polyketals. Global drug-market growth moderates.
May 02, 2006
Washington Report
30
5
Manufacturing and formulation innovation spurs drug develop-ment, but raises new safety and quality issues.